The move takes effect on Jan. 1, it added in a statement. Thomas Schinecker, the incumbent head of the Diagnostics division, is becoming Roche CEO as of March 15, 2023.
(Reporting by Michael Shields; Editing by Christopher Cushing)
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
221 CHF | +1.01% | -0.50% | -9.61% |
Apr. 26 | Roche: positive CHMP opinion for Alecensa | CF |
Apr. 26 | Roche’s Lung Cancer Drug Alecensa Backed for Approval in EU | MT |
ZURICH (Reuters) - Roche Holding has named Matt Sause, head of Roche Diagnostics' North America region, to lead the group's diagnostics business, the Swiss drugmaker said on Monday.
The move takes effect on Jan. 1, it added in a statement. Thomas Schinecker, the incumbent head of the Diagnostics division, is becoming Roche CEO as of March 15, 2023.
(Reporting by Michael Shields; Editing by Christopher Cushing)
1st Jan change | Capi. | |
---|---|---|
-9.61% | 193B | |
+25.83% | 653B | |
+27.00% | 556B | |
-6.76% | 354B | |
+20.34% | 331B | |
+3.00% | 296B | |
+13.09% | 233B | |
+5.46% | 201B | |
-6.26% | 144B | |
-11.77% | 143B |